Progressive supranuclear palsy with dementia: Cortical pathology

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 4, 1999, Pages 359-364

  Bigio, Eileen H ^a   Brown, Daniel F ^a   White III, Charles L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Cortical; Dementia; Pathology; Progressive; Subcortical; Supranuclear palsy; Tau

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONSET AGE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBTHALAMIC NUCLEUS; WHITE MATTER;

EID: 0032941206     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199904000-00006     Document Type: Article

References (39)

1. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The consortium to establish a registry for Alzheimer's disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45(3 Pt 1):461-66
2. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol 1988;24: 50-56
3. Salmon E, Van der Linden MV, Franck G. Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy. Neuroimage 1997;5:173-78
4. Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. [Review] Brain Cogn 1995;28:311-20
5. Litvan I. Cognitive disturbances in progressive supranuclear palsy. [Review] J Neural Transm Suppl 1994;42:69-78
6. Ishino H, Otsuki S. Frequency of Alzheimer's neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy). J Neurol Sci 1976;28:309-16
7. Hauw J-J, Verny M, Delaère P, Cervera P, He Y, Duyckaerts C. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 1990;119:182-6
8. Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S. Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 1995;21: 319-26
9. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease, and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55(1):53-67
10. Chin S S-M, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55(5):499-508
11. Mon H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: A disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 1994;88:113-21
12. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996;40:139-48
13. Nishimura T, Ikeda K, Akiyama H, et al. Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Neurosci Lett 1995;201: 123-26
14. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy: Neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-24
15. Collins S, Ahlskog J, Parisi J, Maraganore DM. Progressive supranuclear palsy: Neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry 1995;58:167-73
16. Verny M, Duyckaerts C, Agid Y, Hauw J-J. The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 1996;119:1123-36
17. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Path 1998;8(2):355-66
18. Bergeron C, Pollanen MS, Weyer L, Lang AE. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 1997; 56(6):726-34
19. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41(4):479-86
20. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42(11):1097-1105
21. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82(4):239-59
22. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33(6):403-8
23. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995;16(3):271-78
24. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997;18(4 Suppl): S85-S88
25. Braak H, Braak E. Staging of Alzheimer-related cortical destruction. Int Psychogeriatr. 9 Suppl 1997;1:257-61
26. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy. J Neuropathol Exp Neurol 1997;55(1):97-105
27. Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 1994;87:572-77
28. Verny M, Duyckaerts C, Delaère P, He Y, Hauw JJ. Cortical tangles in progressive supranuclear palsy. J Neural Transm Suppl 1994;42: 179-88
29. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-59
30. Love S, Saitoh T, Quijada S, Cole GM, Terry RD. Alz-50, Ubiquitin, and tau immunoreactivity of neurofibrillary tangles, Pick bodies, and Lewy bodies. J Neuropathol Exp Neurol 1988;47(4): 393-405
31. Cervós-Navarro J, Schumacher K. Neurofibrillary pathology in progressive supranuclear palsy (PSP). J Neural Transm Suppl 1994;42: 153-64
32. Yamada T, McGeer PL, McGeer EG. Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neuroscience Letters 1992;135:99-102
33. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of T in progressive supranuclear palsy. Ann Neurol 1997;41:277-81
34. Higgins JJ, Litvan I, Pho LT, Li W, Nee LE. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology 1998;50(1):270-73
35. Arima K, Nakamura M, Sunohara N, et al. Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol 1997;93:558-66
36. Flament S, Delacourte A, Verny M, Hauw J-J, Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol 1991;81:591-96
37. Schmidt ML, Huang R, Martin JA, et al. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHF tau. J Neuropathol Exp Neurol 1996;55(5):534-39
38. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 1995;16(3):285-98
39. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52(1):81-88